Source: OINDPnews

Lee's Pharm: Lee's acquires global rights to Windtree's Aerosurf aerosolized KL4 surfactant

Windtree Therapeutics said that it has signed a deal with Lee's Pharmaceutical and its subsidiary Zhaoke Pharmaceutical giving Lee's global rights to develop and commercialize Windtree surfactants for any potential indications, including Aerosurf aerosolized KL4 surfactant for the treatment of premature infants with respiratory distress syndrome. According to Windtree, the deal includes milestone payments worth up to [...]

Read full article »
Est. Annual Revenue
Est. Employees
CEO Avatar


Update CEO

CEO Approval Rating

- -/100

Lee's Pharm is a Private company. Lee's Pharm generates $1M in revenue per employee Lee's Pharm has 2 followers on Owler.